Analysis of human DNA samples with short-read whole-genome sequencing using dragen iterative gvcf genotyper (IGG) caller.
Ended Purchase Order Awarded Last action
- Contract number
- 75N95025P00366
- Awardee
-
Illumina, Inc. UEI KMW3CRWNAAF3
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $47,600
Award facts
- Opportunity
-
- DRAGEN Iterative gVCF Genotyper (IGG) Caller Pre-Solicitation · 75N95025Q00215 · Posted Jul 22, 2025
- Contract value 100% obligated
- $47,600.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- National Institute on Aging National Institutes of Health, Department of Health and Human Services
- NAICS code
- 541380 Testing Laboratories and Services
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 2 offers Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- San Diego, CA 92122, USA
Award details come from SAM.gov/FPDS.
About this award
The National Institute on Aging awarded a $47,600 firm fixed-price purchase order to Illumina, Inc. on September 12, 2025, for analysis of human DNA samples using short-read whole-genome sequencing with the DRAGEN Iterative gVCF Genotyper (IGG) caller. The contract, which has no set-aside designation, will be performed in San Diego, California, with an ultimate completion date of December 11, 2025. This procurement supports the agency's research initiatives focused on understanding genetic factors contributing to neurodegenerative diseases, including amyotrophic lateral sclerosis and frontotemporal dementia, by processing approximately 56,000 existing single-sample gVCF files generated through the DRAGEN alignment pipeline.
Illumina, Inc., a leading biotechnology company specializing in genetic sequencing and genomic analysis technologies, is well-positioned as the prime contractor given its specialized capabilities in advanced DNA and RNA sequencing platforms and bioinformatics software. The company has an established track record of providing genomic sequencing solutions to multiple federal agencies, including the National Institutes of Health, Centers for Disease Control and Prevention, and U.S. Department of Agriculture. The services procured under this contract align with the National Institute on Aging's mission to support biomedical research on age-related diseases through advanced genomic analysis capabilities.
Quick answers
Who was awarded contract 75N95025P00366?
75N95025P00366 was awarded to Illumina, Inc. by National Institute on Drug Abuse (National Institutes of Health) on September 12, 2025.
How much is contract 75N95025P00366 worth?
The government has obligated $47,600 on 75N95025P00366.
Which agency awarded contract 75N95025P00366?
National Institute on Drug Abuse (National Institutes of Health) awarded 75N95025P00366, with funding from National Institute on Aging (National Institutes of Health).
Was contract 75N95025P00366 competed?
The extent of competition for 75N95025P00366 was competed under sap. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award